Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.

@article{Kauhanen2007Fluorine18Ldihydroxyphenylalanine,
  title={Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.},
  author={Saila P Kauhanen and Marko Sepp{\"a}nen and Heikki Minn and R Eero A Gullichsen and Anna Sofia Salonen and Kalle A. Alanen and Riitta Parkkola and Olof Solin and J{\"o}rgen Bergman and Timo Sane and Jorma J O Salmi and Matti V{\"a}lim{\"a}ki and Pirjo Nuutila},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2007},
  volume={92 4},
  pages={
          1237-44
        }
}
CONTEXT AND OBJECTIVE Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET) is a promising method in localizing neuroendocrine tumors. Recently, it has been shown to differentiate focal forms of congenital hyperinsulinism of infancy. The current study was set up to determine the potential of 18F-DOPA PET in identifying the insulin-secreting tumors or beta-cell hyperplasia of the pancreas in adults. PATIENTS AND METHODS We prospectively studied 10 patients with… CONTINUE READING
Highly Cited
This paper has 42 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations